nAPOGEE: A machine-learning platform for clinically actionable pathogenicity assessment of all mitochondrial noncoding variants
Salvatore Daniele Bianco(Casa Sollievo della Sofferenza), Tommaso Biagini(Casa Sollievo della Sofferenza), Agnese Giovannetti(Casa Sollievo della Sofferenza), A. Urbani(Agostino Gemelli University Polyclinic), Marie T. Lott(Children's Hospital of Philadelphia), Leonardo Caporali(Istituto delle Scienze Neurologiche di Bologna), Viviana Caputo(Sapienza University of Rome), Manuel Mangoni(Sapienza University of Rome), Daniele Ghezzi(University of Bologna), Francesco Petrizzelli(Casa Sollievo della Sofferenza), Marta Adinolfi(Casa Sollievo della Sofferenza), Niccolò Liorni(Casa Sollievo della Sofferenza), Shiping Zhang(Children's Hospital of Philadelphia), Alessandro Napoli(Casa Sollievo della Sofferenza), Douglas C. Wallace(Children's Hospital of Philadelphia), Antonio Gasbarrini(Agostino Gemelli University Polyclinic), Andrea Villani(Sapienza University of Rome), Vincent Procaccio(Université d'Angers)
Cited by 0
Related Papers
PINK1 mutations are associated with sporadic early‐onset parkinsonism
|Annals of Neurology|2004|498
Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism
|Human Molecular Genetics|2005|446